Mirae Asset Global ETFs Holdings’s scPharmaceuticals SCPH Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18,315	Closed	-$104K	–	3161
2025 Q3	$104K	Sell	18,315 -397	-2%	-$2.03K	﹤0.01%	2638
2025 Q2	$71.3K	Sell	18,712 -4,275	-19%	-$13.3K	﹤0.01%	2766
2025 Q1	$60.5K	Buy	22,987 +1,014	+5%	+$3.3K	﹤0.01%	2813
2024 Q4	$77.8K	Buy	21,973 +5,827	+36%	+$22.3K	﹤0.01%	2798
2024 Q3	$73.6K	Buy	16,146 +1,503	+10%	+$7.27K	﹤0.01%	2822
2024 Q2	$63.7K	Buy	+14,643	New	+$64.3K	﹤0.01%	2725

Mirae Asset Global ETFs Holdings's SCPH Position: Q4 2025 in Review

Mirae Asset Global ETFs Holdings sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 18,315 shares — an estimated $104K sold.

Mirae Asset Global ETFs Holdings first reported a position in SCPH in Q2 2024 and held it in 6 quarters. The position peaked at $104K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Mirae Asset Global ETFs Holdings reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Mirae Asset Global ETFs Holdings sold 18,315 scPharmaceuticals shares in Q4 2025, an estimated $104K.
Mirae Asset Global ETFs Holdings first reported a position in scPharmaceuticals in Q2 2024 and held it in 6 quarters.
Mirae Asset Global ETFs Holdings's scPharmaceuticals position peaked at $104K in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.